riluzole has been researched along with Amphetamine-Related Disorders in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riluzole is a glutamate regulator and effective in treatment of neuropsychiatric conditions." | 2.90 | Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial. ( Akhondzadeh, S; Bidaki, R; Farahzadi, MH; Moazen-Zadeh, E; Razaghi, E; Zarrindast, MR, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wiah, S | 2 |
| Roper, A | 2 |
| Zhao, P | 2 |
| Shekarabi, A | 2 |
| Watson, MN | 2 |
| Farkas, DJ | 2 |
| Potula, R | 2 |
| Reitz, AB | 2 |
| Rawls, SM | 2 |
| Farahzadi, MH | 1 |
| Moazen-Zadeh, E | 1 |
| Razaghi, E | 1 |
| Zarrindast, MR | 1 |
| Bidaki, R | 1 |
| Akhondzadeh, S | 1 |
1 trial available for riluzole and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Amphetamine-Related Disorders; Craving; Depression; Double-Blind Method; Ex | 2019 |
1 other study available for riluzole and Amphetamine-Related Disorders